Advertisement
BAX vs DIVP
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAX is a StrongBuy and DIVP is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BAX’s FA Score shows that 2 FA rating(s) are green while.
- BAX’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BAX’s TA Score shows that 5 TA indicator(s) are bullish.
- BAX’s TA Score: 5 bullish, 3 bearish.
Price Growth
BAX (@Pharmaceuticals: Other) experienced а +1.49% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +4.59%. For the same industry, the average monthly price growth was +2.06%, and the average quarterly price growth was +18.24%.
Reported Earning Dates
BAX is expected to report earnings on Oct 30, 2025.
Industries' Descriptions
@Pharmaceuticals: Other (+4.59% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
BAX | ||
|---|---|---|
OUTLOOK RATING 1..100 | 25 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 17 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 92 | |
PRICE GROWTH RATING 1..100 | 65 | |
P/E GROWTH RATING 1..100 | 32 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| BAX | DIVP | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 58% | 3 days ago 50% |
| Stochastic ODDS (%) | 3 days ago 59% | 3 days ago 65% |
| Momentum ODDS (%) | 3 days ago 58% | 3 days ago 81% |
| MACD ODDS (%) | 3 days ago 56% | 3 days ago 71% |
| TrendWeek ODDS (%) | 3 days ago 54% | 3 days ago 78% |
| TrendMonth ODDS (%) | 3 days ago 63% | 3 days ago 44% |
| Advances ODDS (%) | 11 days ago 51% | 5 days ago 80% |
| Declines ODDS (%) | 4 days ago 61% | 7 days ago 51% |
| BollingerBands ODDS (%) | 3 days ago 52% | 3 days ago 70% |
| Aroon ODDS (%) | 3 days ago 54% | 3 days ago 90% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XXCH | 27.80 | 0.89 | +3.31% |
| Direxion Daily MSCI Em Mkt Ex Chn Bl 2X | |||
| PYPY | 11.27 | 0.30 | +2.73% |
| YieldMax PYPL Option Income Strategy ETF | |||
| RBUF | 28.32 | 0.33 | +1.16% |
| Innovator U.S. Small Cp 10 Buf ETF - Qt | |||
| BRTR | 50.55 | 0.27 | +0.53% |
| iShares Total Return Active ETF | |||
| JPIB | 48.81 | 0.21 | +0.43% |
| JPMorgan International Bond Opps ETF | |||
BAX and
Correlation & Price change
A.I.dvisor indicates that over the last year, BAX has been closely correlated with ALGN. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if BAX jumps, then ALGN could also see price increases.
| Ticker / NAME | Correlation To BAX | 1D Price Change % | ||
|---|---|---|---|---|
| BAX | 100% | +2.89% | ||
| ALGN - BAX | 68% Closely correlated | +6.33% | ||
| LUNG - BAX | 53% Loosely correlated | +10.46% | ||
| STE - BAX | 51% Loosely correlated | +1.77% | ||
| SYK - BAX | 51% Loosely correlated | +2.44% | ||
| SOLV - BAX | 50% Loosely correlated | +2.15% | ||
More | ||||
DIVP and
Correlation & Price change
A.I.dvisor indicates that over the last year, DIVP has been loosely correlated with PNC. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if DIVP jumps, then PNC could also see price increases.
| Ticker / NAME | Correlation To DIVP | 1D Price Change % | ||
|---|---|---|---|---|
| DIVP | 100% | +1.21% | ||
| PNC - DIVP | 56% Loosely correlated | +3.96% | ||
| DOW - DIVP | 54% Loosely correlated | +5.99% | ||
| BAX - DIVP | 51% Loosely correlated | +2.89% | ||
| CVX - DIVP | 50% Loosely correlated | +1.69% | ||
| UPS - DIVP | 50% Loosely correlated | +3.10% | ||
More | ||||